The wife of the former British Prime Minister and founder of the Cherie Blair Foundation for Women talks with iVillage’s Kelly Wallace about new research by the ExxonMobil Foundation and her foundation on how mobile phones can help women entrepreneurs develop their businesses.
macaulay culkin steve jobs fbi safehouse brown recluse brown recluse front door alyssa bustamante
PARIS (Reuters) – France‘s new left-wing government started work on Thursday with pledges to combat excessive austerity but better manage public finances, marking the debut with a 30 percent cut in pay for President Francois Hollande and all ministers.
The sizeable wage reduction was endorsed at a first meeting of the 34-minister team, a day after Germany’s government awarded rises to its ministers and Chancellor Angela Merkel, whose pay will overtake Hollande‘s.
Pierre Moscovici, France’s newly-appointed finance minister, set the tone, reiterating Hollande’s demand Berlin and other euro zone capitals rework a fiscal pact agreed in March, to add pro-growth measures alongside commitments to deficit reduction.
“What we’ve said is the treaty will not be ratified as it stands,” Moscovici said. “We’re firm on this.”
With a debt crisis again rumbling louder in the euro zone, the minister, a moderate social democrat like Hollande, went to lengths to say the European push did not mean the Socialists would renege on a pledge to balance the country’s books by 2017.
“France is at Europe’s heart and we want to stay there,” he told journalists at a handover with his centre-right predecessor Francois Baroin.
“We’re convinced public debt is an enemy for the country. Our task will be reduce deficits and debt … this is the task we will address first.”
Hollande takes the helm with Europe’s second-largest economy at standstill, the unemployment rate close to 10 percent and the euro zone struggling to contain debts that have spooked markets and forced Greece and others into excruciating bailouts.
In a highly symbolic debut, Hollande chaired a first cabinet meeting where the 17 men and 17 women ministers gave the nod to a pay reduction that will trim salaries by 30 percent, knocking the wage Hollande will earn to just under 15,000 euros ($19,100)a month.
The pay cut, implemented by a decree the ministers approved, takes immediate effect and will require a law but be backdated to mid-May in Hollande’s case, government spokeswoman Najat Vallaud-Belkacem said.
A government statement said the cuts would reduce the gross pay of ministers to 9,940 euros a month from 14,200 euros and cut the salary paid to both Hollande and Prime Minister Jean-Marc Ayrault to 14,910 euros a month, from 21,300 euros.
The cabinet met on a public holiday at the Elysee Palace, the presidential offices vacated by conservative Nicolas Sarkozy on Tuesday after handing Hollande the country’s nuclear codes.
In Germany, which has weathered several years of financial and economic turmoil better than France and far better than the likes of debt-crushed Greece or Ireland, the wage trend was in the opposite direction.
On Wednesday, Merkel’s cabinet gave themselves a 5.7 percent rise that will push Merkel’s pay up by 930 euros per month from her current base pay of just over 16,000 euros a month.
NOT JUST ABOUT CUTBACKS
Hollande’s team, mixing old hands and a lot of new blood, is dominated by moderates and headed by Ayrault, a veteran politician who, like Hollande, has never himself held a national post.
Only five of the 34 ministers have held national government posts before, but several key jobs have gone to long-timers, including Laurent Fabius, who served as France’s youngest prime minister, in 1984 at age 34, under Francois Mitterrand.
Fabius, who campaigned for a “No” vote in a referendum on a European Constitutional treaty in 2005, was keen to sideline that past on Thursday as he took his place in a foreign ministry office once occupied by Robert Schumann, one of the founding father’s of the European Union.
“That’s behind us now,” he told journalists. “What it’s about now is pulling out of the crisis and building something different.”
Like Moscovici, Fabius insisted the government would be as serious about financial restraint as it was about preventing austerity on a scale that could be self-defeating if it did even further damage to economies in recession or almost.
“You have to walk on two legs,” he said. “Budget discipline is one leg and the other leg is economic growth. For now the growth leg isn’t there.”
Hollande, Merkel and other European leaders meet in late May to discuss the matter and Hollande hopes they will agree to alter the pact agreed last March in Brussels, beefing it up with pledges to tap European development funds and even launch joint bonds, known as project bonds, to fund growth-boosting projects.
($1 = 0.7849 euros)
(Additional reporting Yann Le Guernigou, Emmanuel Jarry, Daniel Flynn, John Irish and Erik Kirschbaum; Editing by Sophie Hares)
joe paterno lung cancer john tucker must die uk basketball iowa state faroe islands faroe islands corso
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 16-May-2012
[ | E-mail | 
Share ]
Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
PHILADELPHIA A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking daclizumab. This proof-of-concept study is published this week in Science Translational Medicine. Senior authors of the study are Robert H. Vonderheide, MD, DPhil, associate professor of Medicine, and James Riley, PhD, associate professor of Microbiology.
The team proposed that daclizumab, already used for kidney transplantation, would be effective in depleting regulatory T cells (Tregs) and restoring the immune system’s ability to fight tumors. Tregs are an important population of white blood cells that help turn off the immune system when the system’s job is done. Cancer immunotherapy has been used for the last decade, but researchers have been trying to tweak the system to get immune cells to react more robustly to destroy tumors. In time, though, the body slams on the breaks, rendering vaccines less effective.
Tumor cells exploit Tregs, drawing them to the tumor area. Tregs are essentially hijacked by the tumor, surrounding even the smallest tumors in a protective shell, preventing other tumor-fighting white blood cells from getting to tumor cells at the core.
Tregs rely on a particular protein, called IL-2, for most of their functions. Daclizumab is an antibody that binds to the CD25 receptor on the surface of Tregs to which IL-2 binds. Tregs are deprived of IL-2 in the presence of daclizumab since it binds to the CD25 receptor instead of IL-2. But rather than causing Tregs to die, using normal lymphocytes from a biobank at Penn run by Riley, the team found the lack of IL-2 forces Tregs to convert into normal T cells that no longer surround the tumor. Once this happens, the tumor-fighting immune cells might be able to make their way into the tumor.
To bring this idea to patients, the team then designed a clinical trial, which was directed by co-author Kevin Fox, MD, professor of Medicine, and administered daclizumab to 10 patients with metastatic breast cancer prior to giving them an experimental breast cancer vaccine developed and manufactured at Penn.
“Daclizumab worked incredibly well,” says Vonderheide. There were no detectible side effects, and the T-cell conversion in the patients on daclizumab lasted two months. Their tumors didn’t shrink, but in six out of the 10 patients the tumors did stop growing. And, the daclizumab patients had an increased survival of about seven months compared to patients on the cancer vaccine alone.
To date, says Vonderheide, all previous attempts to eliminate Tregs have been toxic and short-lived, but the effects of daclizumab were observed to be rapid, prolonged, and consistent.
“Although we tested our approach in patients with breast cancer, we know that Tregs can block the immune response against most human cancers,” says Vonderheide. “Drugs like daclizumab might be useful for most cancer patients, especially those receiving other types of immune therapy. Although Tregs do help prevent autoimmunity, we did not observe an autoimmune response because we did not convert all Tregs in the body, only those cells that seem to protect the tumor. Going after only some, but not all Tregs, we believe, was an important and unique aspect of our study. Although there is a great deal of work to do to confirm our findings, we believe this will have major implications for cancer vaccine regimens in other types of cancer.”
Although daclizumab is not currently available from its manufacturer, a second trial with a related FDA-approved drug is slated to open for enrollment at Penn this summer for patients with metastatic breast cancer.
###
This work was supported by the National Cancer Institute of the National Institutes of Health under grant CA111377; the Juvenile Diabetes Research Foundation (JDRF); the Collaborative Centers for Cell Therapy and the JDRF Center on Cord Blood Therapies for Type 1 Diabetes; the Breast Cancer Research Foundation; and the Abramson Family Cancer Research Institute. Vonderheide and co-author Susan Domchek declare a potential financial conflict of interest related to inventorship on a patent regarding hTERT as a tumor-associated antigen for cancer immunotherapy (Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT, U.S. Patent 7851591).
Additional co-authors are Andrew J. Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A. Aqui, Daniel J. Powell Jr., Theresa A. Colligon, Jennifer A. Trosko, Leah I. Leinbach, Charles H. Pletcher, Carol K. Tweed, and Angela DeMichele, all from Penn.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania — recognized as one of the nation’s top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation’s first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 16-May-2012
[ | E-mail | Share ]
Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
PHILADELPHIA A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking daclizumab. This proof-of-concept study is published this week in Science Translational Medicine. Senior authors of the study are Robert H. Vonderheide, MD, DPhil, associate professor of Medicine, and James Riley, PhD, associate professor of Microbiology.
The team proposed that daclizumab, already used for kidney transplantation, would be effective in depleting regulatory T cells (Tregs) and restoring the immune system’s ability to fight tumors. Tregs are an important population of white blood cells that help turn off the immune system when the system’s job is done. Cancer immunotherapy has been used for the last decade, but researchers have been trying to tweak the system to get immune cells to react more robustly to destroy tumors. In time, though, the body slams on the breaks, rendering vaccines less effective.
Tumor cells exploit Tregs, drawing them to the tumor area. Tregs are essentially hijacked by the tumor, surrounding even the smallest tumors in a protective shell, preventing other tumor-fighting white blood cells from getting to tumor cells at the core.
Tregs rely on a particular protein, called IL-2, for most of their functions. Daclizumab is an antibody that binds to the CD25 receptor on the surface of Tregs to which IL-2 binds. Tregs are deprived of IL-2 in the presence of daclizumab since it binds to the CD25 receptor instead of IL-2. But rather than causing Tregs to die, using normal lymphocytes from a biobank at Penn run by Riley, the team found the lack of IL-2 forces Tregs to convert into normal T cells that no longer surround the tumor. Once this happens, the tumor-fighting immune cells might be able to make their way into the tumor.
To bring this idea to patients, the team then designed a clinical trial, which was directed by co-author Kevin Fox, MD, professor of Medicine, and administered daclizumab to 10 patients with metastatic breast cancer prior to giving them an experimental breast cancer vaccine developed and manufactured at Penn.
“Daclizumab worked incredibly well,” says Vonderheide. There were no detectible side effects, and the T-cell conversion in the patients on daclizumab lasted two months. Their tumors didn’t shrink, but in six out of the 10 patients the tumors did stop growing. And, the daclizumab patients had an increased survival of about seven months compared to patients on the cancer vaccine alone.
To date, says Vonderheide, all previous attempts to eliminate Tregs have been toxic and short-lived, but the effects of daclizumab were observed to be rapid, prolonged, and consistent.
“Although we tested our approach in patients with breast cancer, we know that Tregs can block the immune response against most human cancers,” says Vonderheide. “Drugs like daclizumab might be useful for most cancer patients, especially those receiving other types of immune therapy. Although Tregs do help prevent autoimmunity, we did not observe an autoimmune response because we did not convert all Tregs in the body, only those cells that seem to protect the tumor. Going after only some, but not all Tregs, we believe, was an important and unique aspect of our study. Although there is a great deal of work to do to confirm our findings, we believe this will have major implications for cancer vaccine regimens in other types of cancer.”
Although daclizumab is not currently available from its manufacturer, a second trial with a related FDA-approved drug is slated to open for enrollment at Penn this summer for patients with metastatic breast cancer.
###
This work was supported by the National Cancer Institute of the National Institutes of Health under grant CA111377; the Juvenile Diabetes Research Foundation (JDRF); the Collaborative Centers for Cell Therapy and the JDRF Center on Cord Blood Therapies for Type 1 Diabetes; the Breast Cancer Research Foundation; and the Abramson Family Cancer Research Institute. Vonderheide and co-author Susan Domchek declare a potential financial conflict of interest related to inventorship on a patent regarding hTERT as a tumor-associated antigen for cancer immunotherapy (Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT, U.S. Patent 7851591).
Additional co-authors are Andrew J. Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A. Aqui, Daniel J. Powell Jr., Theresa A. Colligon, Jennifer A. Trosko, Leah I. Leinbach, Charles H. Pletcher, Carol K. Tweed, and Angela DeMichele, all from Penn.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania — recognized as one of the nation’s top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation’s first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
james farentino somali pirates navy seals navy seal team 6 tim gunn tim gunn built to last
MEXICO CITY (AP) ? Author Carlos Fuentes, who played a dominant role in Latin America’s novel-writing boom by delving into the failed ideals of the Mexican revolution, died Tuesday in a Mexico City hospital. He was 83.
Fuentes died at the Angeles del Pedregal hospital where he was taken after his personal doctor, Arturo Ballesteros, found him in shock in his Mexico City home. Ballesteros told reporters outside the hospital that the writer had a sudden internal hemorrhage that caused him to lose consciousness.
The loss was immediately mourned worldwide via Twitter and across Mexican airwaves by everyone from fellow Mexican authors Elena Poniatowska and Jorge Volpi to reggaeton artist Rene Perez of the group Calle 13.
“I deeply lament the death of our beloved and admired Carlos Fuentes, a universal Mexican writer,” said President Felipe Calderon on his Twitter account.
The prolific Fuentes wrote his first novel, “Where the Air is Clear,” at age 29, laying the foundation for a boom in Spanish contemporary literature during the 1960s and 1970s. He published an essay on the change of power in France in the newspaper Reforma on Tuesday, the same day he died.
His generation of writers, including Colombia’s Gabriel Garcia Marquez and Peru’s Mario Vargas Llosa, drew global readership and attention to Latin American culture during a period when strongmen ruled much of the region.
Fuentes was the driving force in bringing together the Latin writers who collectively became known as “The Boom”, said Raymond L. Williams, a professor of Latin American literature at the University of California, Riverside.
“It took Fuentes’ vision to say if we unite forces and provide a common political and literary voice, we’ll have more impact,” Williams said. “His home in Pedregal (an upscale Mexico City neighborhood) was the intellectual center what brought a lot of writers together.”
“The Death of Artemio Cruz,” a novel about a post-revolutionary Mexico, brought Fuentes international acclaim.
He was asked in an unpublished 2006 interview why he didn’t mention in the book the target of his criticism, the long-ruling, autocratic Institutional Revolutionary Party, known by its Spanish initials PRI. The PRI is now poised to take back the presidency in July 1 elections.
“There was no need to mention the PRI,” Fuentes answered. “It is present by its absence.”
The strapping, mustachioed author dressed smartly, ate well and moved easily between the capitals of Europe and Mexico City with his equally elegant wife, journalist Silvia Lemus.
His other classics included “Aura,” ”Terra Nostra” and “The Good Conscience.” Many American readers know him for “The Old Gringo,” a novel about San Francisco journalist Ambrose Bierce, who disappeared at the height of the 1910-1920 Mexican Revolution. That book was later made into a 1989 film starring Gregory Peck and Jane Fonda.
Mexican historian Enrique Krauze was considered Fuentes’ harshest critic, saying the writer was out of touch with Mexico. But Krauze acknowledged his talents on Tuesday, calling Fuentes an “author of lasting novels and short stories, a vigorous, enriching presence.”
“That’s all I should say,” he told The Associated Press.
Mexican writer Hector Aguilar Camin said on his Twitter account: “One of a kind. An era, his own genre. A writer for all seasons. To Silvia, all my affection.”
Fuentes himself ventured into Twitter only one day, March 19, 2011.
His last message there read: “There must be something beyond slaughter and barbarism to support the existence of mankind and we must all help search for it.”
Fuentes was often mentioned as a candidate for the Nobel prize but never won one. True to his name, which means “fountains” in Spanish, he was a prolific writer, producing plays and short stories and co-founding a literary magazine. He was also a columnist, political analyst, essayist and critic.
And he was outspoken. Once considered a Communist and sympathizer of Cuba’s Fidel Castro, Fuentes was denied entry into the U.S. under the McCarren-Walter Act. Having spent some of his childhood in the U.S. as the son of a Mexican diplomat, he said it grated on him that his left-of-center politics meant he often was portrayed as anti-American. He was critical of American governments and of a rich country that should attend to its poor, but not of Americans and American culture.
“To call me anti-American is a stupendous lie, a calumny. I grew up in this country. When I was a little boy I shook the hand of Franklin Roosevelt and I haven’t washed it since,” he said with characteristic good humor in an unpublished 2006 interview in Los Angeles.
More recently, as a moderate leftist, Fuentes strongly opposed U.S. policies against immigration and the war on terrorism. He warned about Mexico‘s religious right but also blasted Venezuela’s Hugo Chavez as a “Tropical Mussolini.”
He was very critical of Mexican drug violence that has killed more than 47,500 people since 2006, something he blamed on a failed policy by Calderon to attack organized crime. His 2008 book, “Destiny and Desire: A Novel,” was narrated by a severed head.
Fuentes, like his good friend Garcia Marquez, belonged to the tradition of literary author as social commentator.
“I wear two hats,” he said in the 2006 interview, likening himself to Honore de Balzac in producing a combination of human comedy, acute social portraits and ghost stories.
He said at the time he believed he had many more books in him.
“If I thought I had already peaked, I wouldn’t be sitting here. There’s always another book in there,” he said. There is “the psychosis of the empty page” he admitted, but he said “I sleep, dream, get up, write something.”
He had no favorites among his many books: “They are all my children. Maybe some are cross-eyed, but I love them all.”
Fuentes in 1987 won the Cervantes Prize, the Spanish-speaking world’s highest literary honor.
He also was named in 1997 a commander of the National Order of Merit, France’s highest civilian award given to a foreigner. Spain gave him a Prince of Asturias Award for literature in 1994.
Throughout his life, Fuentes also taught courses at Harvard, Princeton, Columbia and Brown universities in the United States.
Fuentes served as Mexican ambassador to Paris beginning in 1975. He resigned from the foreign service again in 1977 when former President Gustavo Diaz Ordaz was appointed ambassador to Spain, saying he wouldn’t serve with the man who ordered a student massacre in Mexico City, which activists said killed up to 350 people.
A believer that literature allowed him to say what would be censored otherwise, Fuentes also was the subject of censorship.
His mystery novel “Aura,” which narrates a romantic encounter beneath a crucifix with a black Christ that some officials claimed was too racy, was banned from public high schools in Puerto Rico. It also sparked controversy in Mexico in 2001 when a former interior secretary asked the novel to be dropped from a suggested reading list at his daughter’s private junior high school.
Fuentes was born in Panama City on Nov. 11, 1928, to Mexican parents. He lived most of his life abroad, growing up in Montevideo, Uruguay; Rio de Janeiro; Washington, D.C.; Santiago, Chile; and Buenos Aires, Argentina. He later divided his time between homes in Mexico City home and London, where he did most of his writing.
Fuentes was married from 1959 to 1973 to actress Rita Macedo, with whom he had his only surviving daughter.
After the couple divorced, Fuentes married Lemus, and they had two children together. Their son Carlos Fuentes Lemus died from complications associated with hemophilia in 1999, and Natasha Fuentes Lemus died in 2005 after a cardiac arrest.
Fuentes also acknowledged having affairs with actresses including Jeanne Moreau and Jean Seberg.
As he grew older, Fuentes left many novels unfinished with imperfections and “wounds that make the book bleed,” he said.
He continued to publish essays and do public speaking to the very end, including the day he died. In an opinion piece in the newspaper Reforma, he expressed optimism for the new government of Francois Hollande, who was sworn in Tuesday as president of France, saying he hoped it would be “defined less by its technocratic profile and more by what the French understand as ‘humanism’ .”
Fuentes, however, always postponed writing about himself.
“One puts off the biography like you put off death,” he said. “To write an autobiography is to etch the words on your own gravestone.”
___
Associated Press writers Marjorie Miller and E. Eduardo Castillo contributed to this report.
university of kentucky ncaa oakland news alec baldwin alec baldwin college basketball oakland
Knowing If You Can Make a Personal Injury Claim
Exactly what using the range associated with injury becoming a lot more to express minimal, you will find frequently instances where the target isn?t able to create a declare since they?re totally not aware that they?ll help to make an injury declare with regards to exactly what offers occurred for them. The actual broadness from the injury part of lawsuit implies that appropriate instances proceed method past the kind of conditions which are promoted for example journey, slide, drop: this will go method past simply bodily damage. Consequently the objective of this short article is actually provide a short understanding in to circumstances that may amount to an injury declare.
Physical Injury
The actual physical injury may be the standard kind of injury that individuals keep company with once they consider producing statements which arrives within absolutely no little component in order to the truth that it?s this kind of declare that is actually referenced through all the businesses available which promote with regard to sufferers associated with injury to create a declare. In the event that one is regrettable sufficient in order to endure the actual ravages associated with some kind of sickness or even illness which may be brought on by a good behave associated with carelessness compared to this type of situation is actually 1 where an injury declare could be created. Possibly the reason behind the businesses which promote featuring this kind of instances is actually since they?re the simplest kinds of injury instances in order to suffer from: more regularly which not really the actual claimant may obtain payment.
Financial Damage
It?s easy to understand which somebody who offers experienced financial reduction might not be conscious that they?ll help to make an injury declare due to this particular occurring. Reasonably somebody who has already established some thing occur to ensure that these phones generate losses is actually extremely not likely to consider ?Oh I have been hurt right now and thus may go about creating a declare. a Instances happen where an individual will some thing to a different and also the offshoot is actually which their own individual home manages to lose component or even all it?s worth. Ought to this particular function as the situation after that an individual can claim regarding injury.
Problems for Status
A personal injury that?s experienced towards the trustworthiness of an individual may frequently end up being known as slander or even libel as well as even though it?s not intrinsically harmful to some individuals wellness inside a bodily capability any risk of strain as well as tension which this type of point may cause is usually reported because using a following impact on an individual inside a bodily capability. Presently there is often conflictions when this occurs where it?s recognized like a situation that?s in accordance with financial damage. In the event that an individual has their own status impacted after that it may frequently trigger the individual in order to endure additionally inside a monetary capability.
Deliberate Damage
Obviously it?s not usually an instance of the damage that the individual experiences becoming caused by any sort of accident. It really is terrible to consider this however frequently one is injured occasionally due to a few 1 performing some thing deliberately. This is often the kind of felony measures for example real physical damage however it is also caused by an individual becoming negligent inside a capability where they?re a lot more than conscious how the way these people carry out their own matters will probably possess some type of harmful impact with an person. Whenever this is actually the situation it?s usually the issue associated with felony procedures becoming used in addition to presently there becoming reasons with regard to an injury declare to become created. A good example is actually a business proprietor understanding that some thing inside the operating atmosphere associated with his/her workers as being a possible danger, however ignoring to complete something about this.
No related posts.
patriots vs broncos contraband denver vs new england denver broncos vs new england patriots cruise ship sinking vernon davis starship troopers
What’s this? ASUS is teasing a mystery product shrouded in shadows on its Facebook page. From the looks of it, the piano-black hardware is mounted vertically onto a brushed metal cantilevered stand that just oozes style. Our vague, uninformed reckonings make us wonder if it’s not an art-deco styled EeeBox, a desktop PC you’d be ashamed to hide under your desk, or the prettiest router we’ve ever seen. Either way, we’ll keep our eyes peeled and in the meantime, you can cast your own idle speculation into the comments below.
Update: Ah, and here it is: the SBW-06C2X-U 3D Blu-ray writer that supports 6X Blu-ray writing speed! Thanks, Kiran.
ASUS teases mystery product on its Facebook page (update: it’s a 3D Blu-ray writer!) originally appeared on Engadget on Mon, 14 May 2012 08:02:00 EDT. Please see our terms for use of feeds.
Permalink | 
ASUS (Facebook) | Email this | Comments
edgar vs henderson berkshire hathaway ufc 144 james jones james jones aladdin black forest
Chevrolet is planning to introduce a new compact SUV to 140 countries, but the U.S. isn?t one of them.
The name of Chevy?s newest and smallest SUV may sound familiar ? we first saw the Trax micocar in concept form at the 2007 New York auto show. It was powered by a 1.0-liter gasoline engine, but there?s no word on its production powertrain.
The Chevrolet Trax will seat five passengers, but ?because of the strong position of the Equinox, there are no plans to introduce the Trax in the U.S. market,? GM said in a statement.
The Trax will meet the public at the Paris Motor Show in September. Its first market will be Mexico, and it will go on sale there at the end of this year.
Related
2007 New York Auto Show: Chevy’s Three Minicar Concepts
Reseatch the Chevrolet Equinox
More Automotive News on Cars.com
nfl hall of fame 2012 ufc diaz vs condit josephine baker super bowl start time target jason wu gi joe jason wu for target collection
?
When you decide that you want to invest in a security system for your home, it makes sense to choose one that?s going to provide you with the best possible quality for what you can afford. ?Home security is no trivial matter, and if you really want to protect your family, your possessions and your house, it makes sense to seek out a system that has all of the features you want. ?Make sure that you pay attention and watch out for the elements of a good home security system when you first start looking. ?This way, you will avoid paying too much and you?ll get all of the features that will keep your home safe. ?
?
Two way voice communication and wireless window and door contact are two elements you should look for in a good security system. ?These kinds of features help with your peace of mind because you know that any kind of attempt to break in while you sleep or while you?re away will be properly addressed. ?An interior siren is another beneficial element that can go a long way to scaring off an intruder if someone does manage to get inside. ?When you know that your home is monitored around the clock, you will be able to live your life without having to worry about security. ?
?
A wireless motion detector is another feature that can catch any would-be intruders off guard, and activate the security system. ?Of course, you?ll also want a key pad or some other form of control panel where you can set the system and run it on your end. ?A good security company will provide the tools and the instructions on how to use them, so you can be a veritable expert on the system, too. ?The instruction element is quite important, because you don?t want to trigger too many false alarms when you come home or are trying to set it up. ?
?
The ability to meet your budget is also an important element for any security system. ?Some companies charge quite a lot for installation and monthly monitoring of the system. ?If possible, try to find a company who doesn?t charge at all for installation, and who has a lower monitoring cost than the competitors. ?A strong warranty on the equipment is a big benefit, as are extras like more door or window contacts as part of the package. ?Take the time to work out a budget ahead of time and ask questions to make sure the costs fit within it. ?
?
Aside from the security system itself, it?s also a good idea to sign on with a company that has a good deal of experience and a proven track record of success. ?Ask around your neighborhood or look on the company website for testimonials from customers. ?At the end of the day, you want to feel safe and secure and you don?t want to pay a fortune every month to achieve this. ?Pay attention and ask the right questions and you?ll be sure to find a system that works great for you and your family. ?
sweet caroline lottery winning numbers pro bowl roster quirky chrissy teigen chia seeds embers